The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients.

MLA

Wang, Shang-Jui, et al. “The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients.” Cureus, vol. 12, no. 6, June 2020, p. e8767. EBSCOhost, https://doi.org/10.7759/cureus.8767.

APA

Wang, S.-J., Jhawar, S. R., Rivera-Nunez, Z., Silk, A. W., Byun, J., Miller, E., Blakaj, D., Parikh, R. R., Weiner, J., & Goyal, S. (2020). The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients. Cureus, 12(6), e8767. https://doi.org/10.7759/cureus.8767

Chicago

Wang, Shang-Jui, Sachin R Jhawar, Zorimar Rivera-Nunez, Ann W Silk, John Byun, Eric Miller, Dukagjin Blakaj, Rahul R Parikh, Joseph Weiner, and Sharad Goyal. 2020. “The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients.” Cureus 12 (6): e8767. doi:10.7759/cureus.8767.